Тезисы 2014 год
1. Никитина Т.П., Базин И.С., Белоногов А.В., Колесников Г.П., Панина М.В., Борисов П.С., Курбатова К.А., Ионова Т.И. Эффективность геля-пленки «Элима» в сравнении со стандартным лечением кремом «Витамин Ф99» у больных с ладонно-подошвенным синдромом, развившимся на фоне противоопухолевой терапии: результаты пилотного многоцентрового исследования. Злокачественные опухоли. Материалы XVIII Российского онкологического конгресса. 2014. №3: 196–197.
2. Татьяна И. Ионова, Денис А. Федоренко, Татьяна П. Никитина, Кира А. Курбатова, Елена И. Усачева. Опросник для полноформатной оценки симптомов у больных хроническим миелолейкозом – Csp Leuk-CML: результаты валидационного исследования. VIII Raisa Gorbacheva Memorial Meeting "Hematopoietic Stem Cell Transplantation in Children and Adults". Abstracts. 2014.
3. Tatyana I. Ionova, Vladimir Y. Melnichenko, Denis A. Fedorenko, Nikita E. Mochkin, Kira A.Kurbatova, Gary Gorodokin, Andrei A. Novik. Base-line Quality of Life Impairment and Its Potential Prognostic Value in Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (AHSCT). Bone Marrow Transplantation, Vol. 49, Suppl. 1, March 2014, S170.
4. Nikitina T.P., Fedorenko D.A., Kurbatova K.A., Usacheva E.I., Ionova T.I., Gorodokin G.I., Novik A.A. Comprehensive symptom profile in patients with chronic myeloid leukemia: practicability and sensitivity of the new symptom assessment tool CSP Leuk-CML. Haematologica. 2014 (Suppl.). B1674.
5. Ionova T.I., Nikitina T.P., Gritsenko T.A., Ivanova V.L., Kuchma G.B., Shnaider T.V., Sannikova I.V., Usacheva E.I., Fedorenko D.A., Kurbatova K.A. The value of dasatinib therapy in patients with imatinib-resistant or -intolerant chronic myeloid leukemia from physician's and patient's perspective: "real world" outcomes. Haematologica. 2014 (Suppl.). B1675.
6. T. Ionova, T. Nikitina, K. Kurbatova. The usefulness of patient treatment satisfaction questionnaire (PTSQ) in diabetes mellitus (DM) patients. Value in Health. 2014. Vol. 17, Issue 3, A256.
7. T.Ionova, T. Nikitina, K. Kurbatova. Applicability of the new instrument for assessment of hypoglycemia symptoms in diabetes mellitus patients. Value in Health. 2014. Vol. 17, Issue 3, A256.
8. Nikitina T., Ionova T., Kurbatova K., Bazin I., Belonogov A., Kolesnikov G., Panina M., Borisov P. New antioxidant-containing topical formulation for treatment of Hand-Foot Syndrome in cancer patients: physician's and patient's perspective. Annals of Oncology. 2004. Vol. 25 (Supplement 4): iv517–iv541, doi:10.1093/annonc/mdu356.35.
9. Ionova T., Nikitina T., Kurbatova K. Self-reporting Hand-Foot Syndrome (HFS) is practical in cancer patients with chemotherapy-induced dermatological toxicity. Quality of Life Research. 2014. 23(Supplement 1): 111.
10. Ionova T., Fedorenko D., Nikitina T., Kurbatova K. Patient-centered evaluation of treatment outcomes in CML patients after 12 months of second-line treatment: quality of life and symptom burden. Quality of Life Research. 2014. 23(Supplement 1): 67.
11. Tatyana I Ionova, Tatyana P Nikitina, Denis A Fedorenko, Taras A Gritsenko, Valentina L Ivanova, Galina B Kuchma, Tatyana V Shnaider, Inga V Sannikova, Elena I Usacheva, Kira A Kurbatova. Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia from Physician's and Patient's Perspective. Blood. 2014
12. Tatiana P. Nikitina, Denis A. Fedorenko, Kira A.Kurbatova, Taras A. Gritsenko, Valentina L. Ivanova, Galina B. Kuchma, Tatyana V. Shnaider, Inga V. Sannikova, Elena I. Usacheva, Tatyana I. Ionova. Baseline Quality of Life in Chronic Phase Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Imatinib and its Potential Prognostic Value. ELN Frontiers meeting. Abstracts. 2014. P21.
|
